FORTE Study

FORTE study is led by NRG Oncology and is a part of the National Clinical Trials Network (NCTN) program, which is sponsored by the National Cancer Institute (NCI). FORTE is a colorectal cancer prevention study looking to determine how often participants who have had 1-2 small benign polyps removed during colonoscopy from their colon otherwise known as adenomatous polyps or adenomas should have repeat surveillance colonoscopies. The primary goal of FORTE is to compare the colorectal cancer rates between the two study groups (repeat colonoscopy at 5 and 10 years versus repeat colonoscopy at 10 years) to see if the rates are equivalent. If they are equivalent, then people in the future would likely be recommended to only undergo a 10-year exam and the 5-year exam may not be necessary. Participants will be asked to donate blood and stool samples and will be followed annually.

Website

https://www.nrgoncology.org/Clinical-Trials/NRG-CC005

External link for FORTE Study

Industry

Research Services

Company size

2-10 employees

Headquarters

Pittsburgh, PA

Type

Nonprofit

Founded

2021

Specialties

Cancer Prevention, Research, Colorectal Cancer, Surveillance Colonoscopy